References
- Weyand C, Goronzy J. Giant-cell arteritis and polymyalgia rheumatica. Ann Int Med 2003; 139: 505–15
- Le Hello C, Lévesque H, Jeanton M, Cailleux N, Galateau F, Peillon C, et al. Lower limb giant cell arteritis and temporal arteritis: follow-up of 8 cases. J Rheumatol 2001; 28: 1407–12
- Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A. Ultrasound of the proximal upper extremity arteries to increase the diagnostic yield in large vessel giant-cell arteritis. Rheumatology 2008; 47: 96–101
- Blockmans D, de Cueninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006; 55: 131–7
- Smetana GW, Shmerling RH. Does this patient have temporal arteritis?. J Am Med Assoc 2002; 287: 92–101
- Salvariani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Rheum 2001; 45: 140–5
- Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large vessel vasculitis: an update. Rheumatology 2008; 47: 403–8
- Eshagian J, Goeken JA. C-reactive protein in giant cell (cranial) arteritis. Ophthalmology 1980; 87: 1160–6
- Kyle V, Cawston TE, Hazleman B. Erythrocyte sedimentation rate and C-reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow-up. Ann Rheum Dis 1989; 48: 667–71
- Both M, Ahmadi-Simab K, Reuter M, Dourvos O, Fritzer E, Ullrich S, et al. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis 2008; 67: 1030–3